Surveillance of Invasive Fungal Infections in Bone Marrow/Stem Cell and Solid Organ Transplantation Recipients and Other Immunocompromised Patients: A Prospective Study
Sponsor study identifier
Secondary identifiers
observational
217
1 country
1
Study Start
April 9, 2001
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
July 17, 2012
Date type not reportedThis date has not been verified as actual or estimated.
This study will collect data on the incidence (rate of occurrence) of fungal infections in recipients of bone marrow, stem cell or organ transplants. The data will provide information needed to develop strategies for prevention and early treatment of fungal infections in these patients. Any patient receiving bone marrow transplantation, peripheral stem cell transplantation or solid organ transplantation is eligible for this study. The survey will be conducted over a 3-year period at about 20 collaborating transplant centers. Through the annual accrual of more than 9,000 patients, it is estimated that at least 5 to 8 percent per year will have documented or suspected invasive fungal infections. The study will be conducted in three phases as follows:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 17, 2012
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 9, 2001
Date type not reportedThis date has not been verified as actual or estimated.
November 14, 2001
Actual (reported)November 15, 2001
Actual (reported)July 17, 2012
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Crystal L Mackall, M.D.
National Cancer Institute (NCI)
217 participants (actual enrollment reported by the registry).
First Submitted
November 14, 2001
First Posted
November 15, 2001
Study Start
April 9, 2001
Date type not reportedThis date has not been verified as actual or estimated.
PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)
Study Completion
July 17, 2012
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
December 17, 2019
Record last verified: 2012-07-17
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: